Relay Therapeutics — protein motion drug discovery (Dynamo platform)

ArriVent BioPharma is a clinical-stage biopharmaceutical company focused on the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with difficult-to-treat diseases, beginning with cancers.

Alpha-9 Oncology is a clinical-stage radiopharmaceutical company developing targeted radioligand therapies and imaging agents to treat solid and hematologic cancers with high precision.

Chimerix, Inc. was a biopharmaceutical company headquartered in Durham, North Carolina, focused on developing medicines for serious and life-threatening diseases. It is best known for brincidofovir (TEMBEXA), an antiviral approved by the U.S.

Areteia Therapeutics was a clinical-stage biotechnology company, formerly based in Chapel Hill, North Carolina, operating in the life-sciences sector. As of the July 2026 enrichment pass the company is no longer operating: areteiatx.com serves only a closure notice directing asset and general inquiries to contact addresses, and the company…

Escient Pharmaceuticals is a San Diego, California clinical-stage biopharmaceutical company developing first-in-class, oral small-molecule therapeutics targeting Mas-related G protein-coupled receptors (MRGPRs) along the neurosensory-inflammatory axis.

Engrail Therapeutics is a clinical-stage biopharmaceutical company founded in 2019 and focused on precision neuroscience. The company develops innovative, precision-targeted small-molecule therapeutics aimed at the molecular mechanisms and neural circuits underlying nervous system disorders, combining internal discovery with strategic…

Basking Biosciences is a clinical-stage biopharmaceutical company in Research Triangle, North Carolina (with operations in Mitchelton, Queensland, Australia) developing novel therapies for life-threatening blood clots.

Iterum Therapeutics plc is a clinical-stage pharmaceutical company headquartered in Dublin, Ireland, focused on developing novel anti-infective medications to treat multi-drug resistant (MDR) bacterial infections.

Alpha-9 Oncology is a clinical-stage radiopharmaceutical company that spun out of the University of British Columbia and BC Cancer in 2019 to develop a portfolio of targeted cancer therapies.

Braveheart Bio is a late clinical-stage biopharmaceutical company developing novel therapeutics for hypertrophic cardiomyopathy (HCM) and related cardiac conditions. Its lead candidate, BHB-1893, is a selective cardiac myosin inhibitor (licensed as HRS-1893 from Hengrui Pharma) designed to reduce excessive heart-muscle contraction and improve…

Aer Therapeutics is a clinical-stage biopharmaceutical company based in the Research Triangle Park / Raleigh area of North Carolina, developing novel treatments for muco-obstructive lung diseases such as COPD, asthma, cystic fibrosis, and non-CF bronchiectasis. A spinout from Dr.

kechowpharma — Kechow Pharma (Shanghai Kezhou Pharmaceutical Co., Ltd.) is a clinical-stage biopharmaceutical company founded in 2014 and headquartered in Shanghai's Zhangjiang High-Tech Park.

Apreohealth — Apreo Health is a clinical-stage medical device company based in Menlo Park, California, developing a novel, tissue-sparing bronchoscopic treatment for severe emphysema.

Erasca is a clinical-stage precision oncology company (NASDAQ: ERAS) headquartered in San Diego, California, whose name is its mission: to erase cancer. The company is singularly focused on discovering, developing, and commercializing therapies for RAS- and MAPK pathway-driven cancers.

Kailera Therapeutics is a clinical-stage biopharmaceutical company focused on the next generation of obesity and cardiometabolic care through a diversified pipeline of GLP-1 based therapies.

Connect Biopharma is a clinical-stage biopharmaceutical company headquartered in San Diego, California, dedicated to transforming care for patients with inflammatory diseases such as asthma and COPD.

Barinthus Biotherapeutics plc (Nasdaq: BRNS) is a clinical-stage biopharmaceutical company developing novel immunotherapies designed to guide and reprogram T cells to overcome autoimmunity, inflammatory disease, chronic viral infection, and cancer.

Grey Wolf Therapeutics (Greywolf Therapeutics) is a clinical-stage biotechnology company developing a new therapeutic class of immunotherapies through antigen modulation, aimed at treating people living with cancers and autoimmune disorders.

Affinia Therapeutics is a clinical-stage biotechnology company in Waltham, Massachusetts pioneering next-generation adeno-associated virus (AAV) gene therapies. Using AI and structural modeling to rationally design novel capsids that better target tissues for improved safety and effectiveness, Affinia develops therapeutic cargoes for devastating…